Literature DB >> 3721712

An intravitreal cannula system: long-term follow-up study.

T Ishibashi, K Miki, R Patterson, S J Ryan.   

Abstract

An intravitreal cannula for chronic drug delivery was implanted in the eyes of two rabbits and one monkey. The rabbits were followed up for three years after surgery and the monkey was followed up for two and one-half years. Clinical observations did not reveal any adverse effects from the cannula implantation. Patency of the cannula was demonstrated by using sodium fluorescein. Histopathological studies with light and electron microscopy revealed the scar tissue around the cannula to be minimal and localized to the wound site. The optic nerve and the retina and choroid at the posterior pole did not show any abnormalities. These results suggest that this system can be used for repeated or continuous drug delivery to the vitreous over a long period of time in experimental models.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3721712     DOI: 10.1007/bf00225932

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  7 in total

1.  Reduction of intraocular pressure using plastics in surgery.

Authors:  R A ELLIS
Journal:  Am J Ophthalmol       Date:  1960-11       Impact factor: 5.258

2.  Anterior chamber tube shunt to an encircling band in the treatment of neovascular glaucoma.

Authors:  S S Schocket; V Lakhanpal; R D Richards
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

3.  A method for chronic drug infusion into the eye.

Authors:  K Miki; H Ohkuma; S J Ryan
Journal:  Jpn J Ophthalmol       Date:  1984       Impact factor: 2.447

4.  Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate.

Authors:  T Ishibashi; K Miki; N Sorgente; R Patterson; S J Ryan
Journal:  Arch Ophthalmol       Date:  1985-05

5.  Cefsulodin concentrations in rabbit eyes after intravenous and subconjunctival administration.

Authors:  U Mester; C Krasemann; H Werner
Journal:  Ophthalmic Res       Date:  1982       Impact factor: 2.892

6.  The penetration of gentamicin into the vitreous humor in man.

Authors:  E Rubinstein; J Goldfarb; G Keren; M Blumenthal; G Treister
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-05       Impact factor: 4.799

7.  Oxacillin for bacterial endophthalmitis: subconjunctival, intravenous, both, or neither?

Authors:  M Barza; A Kane; J Baum
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-11       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.